Scarica l'app Stockscreener
1.91
1.82%
-0.01
Stereotaxis Inc Borsa (STXS) Ultime notizie
Stereotaxis to acquire Robocath for $20M upfront - MSN
Why Stereotaxis (STXS) Could Be One of the Best Robotics Stocks to Buy Under $30 - Insider Monkey
5 Best Robotics Stocks to Buy Under $30 - Insider Monkey
Stereotaxis stock up on first US MAGIC procedures post approval - MSN
Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - MSN
STXS to acquire Robocath to lead in endovascular robotics market - MSN
Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - MSN
Stereotaxis, Inc. spotlights RoboticEP system during interactive sessions at HRS2026 - Traders Union
Stereotaxis wins FDA clearance for Synchrony system, launches platform - MSN
Stereotaxis Stock Up on First U.S. MAGiC Procedures Post Approval - TradingView
Stereotaxis’ Catheter Earns Early Clinical Success Following FDA Approval - Diagnostic and Interventional Cardiology
Stereotaxis Has 1st U.S. Procedures with MAGiC Cardiac Ablation Catheter - Medical Product Outsourcing
Stereotaxis, Inc. enables first U.S. robotic arm procedures for complex CHD cases - Traders Union
Stereotaxis Announces First MAGiC Procedures in the United States - ChartMill
After the close, Stereotaxis will break down Q1 results on May 12 - Stock Titan
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewswire
Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform - Indian Pharma Post
Net current asset value per share of Stereotaxis, Inc. – LSX:A1J09L - TradingView
Stereotaxis to Acquire Robocath in Strategic 45 Million Dollar Deal - HarianBasis.co
Stereotaxis, Inc. sets sights on HRS2026 with live robotics demonstration - Traders Union
STXS to Acquire Robocath to Lead in Endovascular Robotics Market - TradingView
Stereotaxis to acquire Robocath for up to $45m - Yahoo Finance
Stereotaxis (STXS) to Acquire Robocath in Multi-Million Dollar D - GuruFocus
Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover - Benzinga
Stereotaxis to buy Robocath for up to $45M - MedTech Dive
Stereotaxis to Buy Robocath for up to $45M - Medical Product Outsourcing
St. Louis robotic surgery firm acquires French competitor - The Business Journals
Stereotaxis to acquire Robocath for up to $45M - MassDevice
Stereotaxis to Acquire Robocath in Strategic Robotics Deal - TipRanks
Stereotaxis to Acquire Robocath in Deal Worth Up to $45 Million - marketscreener.com
Stereotaxis to Acquire Robocath With $20M Upfront, Up to $25M Earnouts; Provides Interim Financing - TradingView
Stereotaxis to acquire Robocath for up to $45 million By Investing.com - Investing.com Canada
Stereotaxis (STXS) plans Robocath acquisition with $20M upfront and $25M earnout - Stock Titan
Stereotaxis Announces Definitive Agreement to Acquire Robocath - ChartMill
Stereotaxis, Inc. agreed to acquire an unknown majority stake in Robocath SAS for $45 million. - marketscreener.com
Stereotaxis, Inc. urges final day visits at EHRA2026 for hands on robotic EP demonstrations - Traders Union
Stereotaxis (STXS) CFO awarded 40,000 options at $1.87 strike price - Stock Titan
Aug Drivers: Is Stereotaxis Inc being accumulated by smart money2026 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Inflation Data: Can Stereotaxis Inc keep up with sector leaders2026 Trading Volume Trends & Community Driven Trade Alerts - baoquankhu1.vn
Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN
Stereotaxis, Inc. promotes GenesisX at EHRA2026 kickoff in Paris - Traders Union
Bank Watch: Does Stereotaxis Inc align with a passive investing strategy2026 Year in Review & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Stereotaxis bags FDA clearance for next-gen cath lab tech - Indian Pharma Post
St. Louis-based Stereotaxis gets FDA clearance for new cath lab software platform - The Business Journals
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance Australia
STXS Rises After FDA Approval for Synchrony System, Broadens Digital Surgery Portfolio - Bitget
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery - TradingView
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):